MDMA Prescriber Training

Welcome to our MDMA prescriber training program!

Instructed by industry leaders Dr. Ingrid Pacey, Dr. Houman Farzin and Jagpaul Keor Deol, this online, 1/2-day training is the key to enhancing your skills and learning about MDMA-assisted psychotherapy.

Apply below for our first cohort:
April 30, 2024 (9am-3pm PST via Zoom)

Introduction

TheraPsil’s fundamental mission is to provide access to legal psychedelic-assisted psychotherapy for Canadians in medical need. Our primary functions involve patient-rights advocacy, clinical assessment, training, and connecting patients with suitable therapists for treatment.

We recognize the importance of developing a strong foundation of suitably trained and trusted physicians who can support patients seeking psilocybin and MDMA-assisted psychotherapy for treatment. To this end, TheraPsil has developed an MDMA prescriber-specific training program, and we contract with individuals and organizations to deliver it.

We are dedicated to clinical, academic, and ethical excellence in psychedelic treatment. We understand that this requires equitable access for all clinicians to our training program so that our patients have access to a diverse range of therapists. We respect and welcome diversity, and warmly encourage members of ethnic, BIPOC, LGBTQIA2S+, gender, religious, and other underserved or marginalized communities to apply.

Our training goal is to fully prepare our graduates to safely and effectively prescribe MDMA to clients under Canada’s Special Access Program (SAP). TheraPsil will then connect our trained prescribers with treatment teams of therapists who have completed TheraPsil’s Intensive Training Program so they can work together to best support patients through all aspects of MDMA treatment.

Our Prescriber Training Program

  • Our MDMA prescriber training program consists of 6 curriculum units listed and described below;
  • Trainees will begin with a set of pre-readings and videos. They then attend a seminar involving online instruction covering units 1-6;
  • Seminars involve knowledge and skill acquisition, self-reflection, and community building. They involve a flexible mixture of lectures, large and small group discussions, case studies, and skill-practice sessions;
  • Seminars may involve the use of “guest” expert presenters for certain topics;
  • Online seminar delivery may be scheduled flexibly according to the needs of cohort members (e.g. ½ day intensives, weekly or bi-weekly sessions stretching over a month);
  • Maximum cohort size: 30 members;
  • Delivery method: Zoom;
  • Community platform and training portal: Mighty Networks;
  • We expect that our curriculum, with its current scope for patient treatment for PTSD through Health Canada’s Special Access Program, will broaden in focus as our patient inclusion criteria expands to include compassionate treatment of anxiety, substance use disorder, and pain management;
  • Trainees will have the opportunity to deliver feedback to the trainers throughout, and proceeding the program concerning program content and delivery;
  • Total Program Hours:
      • Online Seminar 6
      • Pre-readings/videos 2
      • 8 hours

Entrance Requirements

  1. A medical degree (MD, NP, DO, ND, PA);
  2. Current good standing as a member of a professional provincial governing body such as the College of Physicians and Surgeons, BC College of Nurses and Midwives,
  • Preference will be given to applicants who already have personal or professional psychedelic experience;
  • Each applicant will be admitted to the prescriber training program following a successful review of the training application form by the Director of Training and Operations to assess personal and professional suitability.

Graduation Requirements

  • Completion of in-person training seminar (Units 1-6). Full attendance is required;
  • Certification of completion of readings and videos;
  • Completion of knowledge checks and quizzes

Certificates & Professional Designations

  • A qualified professional accepted into our program becomes a TheraPsil Affiliate by committing to complete our MDMA prescriber training program;
  • Prescriber trainees who have fully attended the 6-hour seminar, and  certified that they have completed all required readings and videos may receive (upon request) a certificate of completion of 8 hours of didactic instruction in TheraPsil’s MDMA-Assisted Prescriber Training Program. 
    • To certify that didactic training is complete and receive a certificate of completion, email support@therapsil.ca
  •  This certificate will identify them as a TheraPsil Prescriber, and their names will be entered into TheraPsil’s register of prescribers.  This register is made available to prospective patients seeking assessment or SAP application support and treatment teams seeking prescribers.

Seminar Content

Program Learning materials: texts, readings and videos

Learning materials (including texts, other readings, and videos) for each cohort will be determined by the instructor(s) assigned to the cohort via TheraPsil’s online training portal, Mighty Networks.

Continuing Medical Education (CME) Credits

TheraPsil’s Prescriber Training Program is under application to be certified for up to 8 Mainpro+® credits.